Gerard Groenewegen

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 364 citations · Full text

Surgical Oncology, Medicine, Melanoma +8

Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial

Alexander M.M. Eggermont, Stefan Suciu, Rona M. MacKie et al. · The Lancet · 2005 · 310 citations

Surgical Oncology, Oncology, Melanoma +7

Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium

A.W Griffioen, C.A. Damen, G.H. Blijham et al. · Blood · 1996 · 296 citations · Full text

Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors.

Arjan W. Griffioen, C.A. Damen, Stefano Martinotti et al. · PubMed · 1996 · 284 citations

Cell Adhesion, Immunology, Angiogenic Factors +18

Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies

Gordon C. Jayson, Jamal Zweit, Alan Jackson et al. · JNCI Journal of the National Cancer Institute · 2002 · 257 citations · Full text